[1]
Fediak, I. and Volosheniuk, T. 2024. Marketing study of selective serotonin reuptake inhibitors for the treatment of post-traumatic stress disorder in military servants and war veterans. ScienceRise: Pharmaceutical Science. 6(52) (Dec. 2024), 90–102. DOI:https://doi.org/10.15587/2519-4852.2024.308684.